Raymond James analyst John Davis lowered the firm’s price target on Corpay (CPAY) to $392 from $414 and keeps an Outperform rating on the shares. The company reported inline Q2 results but is seeing weakness in lodging, the analyst tells investors in a research note. The firm, which says Corpay’s weakness is isolated to lodging, continuec to recommend the stock.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay, Inc. Reports Strong Q2 Growth and Strategic Moves
- Corpay Inc: Positioned for Strong Growth with Strategic Acquisitions and Fintech Innovations
- Corpay Inc Reports Strong Q2 2025 Financial Results
- Corpay reports Q2 adjusted EPS $5.13, consensus $5.12
- Corpay sees FY25 adjusted EPS $20.86-$21.26, consensus $21.06